Xianglei Yan

Artiklar

Article: ANTIBODIES. 2024;13(2):31
Fcγ-Receptor-Independent Controlled Activation of CD40 Canonical Signaling by Novel Therapeutic Antibodies for Cancer Therapy
Beckmann K; Reitinger C; Yan X; Carle A; Bluemle E; Jurkschat N; Paulmann C; Prassl S; Kazandjian LV; Lore K; Nimmerjahn F; Fischer S
Article: CELLULAR AND MOLECULAR LIFE SCIENCES. 2023;80(7):189
Cell targeting and immunostimulatory properties of a novel Fcγ-receptor-independent agonistic anti-CD40 antibody in rhesus macaques
Yan X; Ols S; Arcoverde Cerveira R; Lenart K; Hellgren F; Ye K; Cagigi A; Buggert M; Nimmerjahn F; Hojen JF; Parera D; Pessara U; Fischer S; Lore K
Article: MOLECULAR THERAPY: METHODS & CLINICAL DEVELOPMENT. 2022;27:309-323
A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses
Lenart K; Hellgren F; Ols S; Yan X; Cagigi A; Cerveira RA; Winge I; Hanczak J; Mueller SO; Jasny E; Schwendt K; Rauch S; Petsch B; Lore K